Data / Form D filings / EnGeneIC Ltd
EnGeneIC Ltd: Form D filings
EnGeneIC Ltd, a biotechnology company in New South Wales, Australia, filed 2 Form D notices with the SEC between 2015 and 2017. The latest, on April 13, 2017, reports $150,000 sold of a $10 million offering to 3 investors.
Find out what EnGeneIC Ltd does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- BUILDING 2, 25 SIRIUS ROAD, LONE COVE, New South Wales, Australia, 2066
- Phone
- (917) 471-0710
- Industry
- Biotechnology
- Entity type
- Other (Bermuda Exempted Company)
- Incorporated in
- Bermuda
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1648902
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2017 | New notice | $10,000,000 | $150,000 | $9,850,000 | 3 | Apr 4, 2017 | sec.gov |
| Jul 29, 2015 | New notice | $6,000,000 | $2,905,000 | $3,095,000 | 5 | Mar 12, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mervyn Turner | Director | |
| Yvonne Perlberg | Director | |
| Richard Woods | Director | |
| David Seaton | Executive Officer | |
| Himanshu Brahmbhatt | Executive Officer, Director, Promoter | |
| Edward Miller | Director | |
| Jennifer MacDiarmid | Executive Officer, Director, Promoter |
Every Form D from the week of Apr 10, 2017 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EnGeneIC Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.